As European markets continue to rally, driven by slowing inflation and optimistic economic sentiment, investors are increasingly looking toward growth opportunities in stable economies like Sweden. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company.
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Truecaller (OM:TRUE B) | 29.5% | 21.6% |
Fortnox (OM:FNOX) | 21.1% | 22.6% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Biovica International (OM:BIOVIC B) | 18.8% | 73.1% |
BioArctic (OM:BIOA B) | 34% | 98.4% |
Yubico (OM:YUBICO) | 37.5% | 42.5% |
KebNi (OM:KEBNI B) | 37.8% | 86.1% |
InCoax Networks (OM:INCOAX) | 19% | 115.5% |
Calliditas Therapeutics (OM:CALTX) | 12.7% | 51.9% |
Click here to see the full list of 93 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK28.32 billion.
Operations: The company's revenue is primarily derived from Healthcare Services (€1.32 billion) and Diagnostic Services (€610 million).
Insider Ownership: 11.1%
Medicover, a growth company with high insider ownership in Sweden, recently announced revenue guidance exceeding €2.2 billion for year-end 2025 and reported strong earnings growth, with second-quarter sales of €509.4 million and net income of €6.3 million. The company is expected to see significant annual profit growth at 38.6%, outpacing the Swedish market's forecasted 15.1%. With no substantial insider selling and new CFO Anand Patel joining soon, Medicover remains well-positioned for future expansion despite interest payments not being well covered by earnings.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Vimian Group AB (publ) operates in the global animal health sector and has a market capitalization of SEK22.47 billion.
Operations: Vimian Group AB (publ) generates revenue from four primary segments: Medtech (€111.91 million), Diagnostics (€20.63 million), Specialty Pharma (€158.39 million), and Veterinary Services (€53.95 million).
Insider Ownership: 11.1%
Vimian Group, characterized by high insider ownership, reported second-quarter sales of €90.99 million and net income of €4.87 million, showing year-over-year growth. Earnings are forecast to grow significantly at 62.89% annually over the next three years, outpacing the Swedish market's 15.1%. Despite trading at 30.3% below fair value and having substantial insider buying recently, revenue growth is expected to be slower than 20% per year but faster than the market average of 0.9%.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Wallenstam AB (publ) is a property company operating in Sweden with a market cap of SEK35.68 billion.
Operations: In 2023, Wallenstam's revenue segments included SEK938 million from Stockholm and SEK1.94 billion from Gothenburg.
Insider Ownership: 35%
Wallenstam, a growth company with high insider ownership, reported significant financial improvements in Q2 2024 with sales of SEK 737 million and net income of SEK 74 million. Earnings are forecast to grow at 53.6% annually over the next three years, surpassing the Swedish market's average. Recent initiatives include sustainable office developments at Kaserntorget 6, attracting diverse tenants and promoting circular material flows. However, interest payments are not well covered by earnings.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include OM:MCOV B OM:VIMIAN and OM:WALL B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。